Cannara Biotech Inc.

TSXV LOVE.V

Cannara Biotech Inc. Shares (Diluted, Weighted) for the year ending August 31, 2024: 91,385,025

Cannara Biotech Inc. Shares (Diluted, Weighted) is 91,385,025 for the year ending August 31, 2024, a 2.33% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.
  • Cannara Biotech Inc. Shares (Diluted, Weighted) for the year ending August 31, 2023 was 89,300,448, a 1.66% change year over year.
  • Cannara Biotech Inc. Shares (Diluted, Weighted) for the year ending August 31, 2022 was 87,840,476, a 14.80% change year over year.
  • Cannara Biotech Inc. Shares (Diluted, Weighted) for the year ending August 31, 2021 was 76,515,158, a 7.26% change year over year.
  • Cannara Biotech Inc. Shares (Diluted, Weighted) for the year ending August 31, 2020 was 71,333,277, a 0.93% change year over year.
Key data
Date Shares (Diluted, Weighted) Revenue Cost of Revenue Gross Profit
Market news
SV Wall Street
TSXV: LOVE.V

Cannara Biotech Inc.

CEO Mr. Zohar Krivorot
IPO Date Jan. 14, 2019
Location Canada
Headquarters 333 Decarie Blvd.
Employees 461
Sector Consumers Staples
Industries
Tobacco Alcoholic Beverages Bread & Bakery Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care
Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

StockViz Staff

February 7, 2025

Any question? Send us an email